Hematological particularities and co-infections in injected drug users with AIDS

Detalhes bibliográficos
Autor(a) principal: Brunetta,Denise Menezes
Data de Publicação: 2013
Outros Autores: De Santis,Gil Cunha, Vilar,Fernando Crivelenti, Brandão,Renata Amorim, Muniz,Renata Zomer de Albernaz, Lima,Geovana Momo Nogueira de, Amorelli-Chacel,Manuela Emiliana, Covas,Dimas Tadeu, Machado,Alcyone Artioli
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Brazilian Journal of Infectious Diseases
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702013000600005
Resumo: HIV patients infected through injected drug use have poorer prognosis than other groups. We evaluated the hematological alterations and rates of co-infections in injected drug use patients with AIDS. Injected drug use patients were younger, predominantly of male gender, and presented lower CD4, total lymphocyte, and platelet counts, but not neutrophil count, than control group. Injected drug use patients had a higher rate of hepatitis C and mycobacteria infection. Furthermore, all injected drug use patients with hemoglobin <10.0 g dL-1 and lymphocyte <1000 µL-1 had CD4 count lower than 100 µL-1. In conclusion, HIV-infected injected drug use patients constitute a special group of patients, and hemoglobin concentration and lymphocyte count can be used as surrogate markers for disease severity.
id BSID-1_7a7466d057cebd75cc4733a12305e27e
oai_identifier_str oai:scielo:S1413-86702013000600005
network_acronym_str BSID-1
network_name_str Brazilian Journal of Infectious Diseases
repository_id_str
spelling Hematological particularities and co-infections in injected drug users with AIDSAIDSInjected drug useAnemiaHCVMycobacteriaHIV patients infected through injected drug use have poorer prognosis than other groups. We evaluated the hematological alterations and rates of co-infections in injected drug use patients with AIDS. Injected drug use patients were younger, predominantly of male gender, and presented lower CD4, total lymphocyte, and platelet counts, but not neutrophil count, than control group. Injected drug use patients had a higher rate of hepatitis C and mycobacteria infection. Furthermore, all injected drug use patients with hemoglobin <10.0 g dL-1 and lymphocyte <1000 µL-1 had CD4 count lower than 100 µL-1. In conclusion, HIV-infected injected drug use patients constitute a special group of patients, and hemoglobin concentration and lymphocyte count can be used as surrogate markers for disease severity.Brazilian Society of Infectious Diseases2013-12-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702013000600005Brazilian Journal of Infectious Diseases v.17 n.6 2013reponame:Brazilian Journal of Infectious Diseasesinstname:Brazilian Society of Infectious Diseases (BSID)instacron:BSID10.1016/j.bjid.2013.03.010info:eu-repo/semantics/openAccessBrunetta,Denise MenezesDe Santis,Gil CunhaVilar,Fernando CrivelentiBrandão,Renata AmorimMuniz,Renata Zomer de AlbernazLima,Geovana Momo Nogueira deAmorelli-Chacel,Manuela EmilianaCovas,Dimas TadeuMachado,Alcyone Artiolieng2015-06-26T00:00:00Zoai:scielo:S1413-86702013000600005Revistahttps://www.bjid.org.br/https://old.scielo.br/oai/scielo-oai.phpbjid@bjid.org.br||lgoldani@ufrgs.br1678-43911413-8670opendoar:2015-06-26T00:00Brazilian Journal of Infectious Diseases - Brazilian Society of Infectious Diseases (BSID)false
dc.title.none.fl_str_mv Hematological particularities and co-infections in injected drug users with AIDS
title Hematological particularities and co-infections in injected drug users with AIDS
spellingShingle Hematological particularities and co-infections in injected drug users with AIDS
Brunetta,Denise Menezes
AIDS
Injected drug use
Anemia
HCV
Mycobacteria
title_short Hematological particularities and co-infections in injected drug users with AIDS
title_full Hematological particularities and co-infections in injected drug users with AIDS
title_fullStr Hematological particularities and co-infections in injected drug users with AIDS
title_full_unstemmed Hematological particularities and co-infections in injected drug users with AIDS
title_sort Hematological particularities and co-infections in injected drug users with AIDS
author Brunetta,Denise Menezes
author_facet Brunetta,Denise Menezes
De Santis,Gil Cunha
Vilar,Fernando Crivelenti
Brandão,Renata Amorim
Muniz,Renata Zomer de Albernaz
Lima,Geovana Momo Nogueira de
Amorelli-Chacel,Manuela Emiliana
Covas,Dimas Tadeu
Machado,Alcyone Artioli
author_role author
author2 De Santis,Gil Cunha
Vilar,Fernando Crivelenti
Brandão,Renata Amorim
Muniz,Renata Zomer de Albernaz
Lima,Geovana Momo Nogueira de
Amorelli-Chacel,Manuela Emiliana
Covas,Dimas Tadeu
Machado,Alcyone Artioli
author2_role author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Brunetta,Denise Menezes
De Santis,Gil Cunha
Vilar,Fernando Crivelenti
Brandão,Renata Amorim
Muniz,Renata Zomer de Albernaz
Lima,Geovana Momo Nogueira de
Amorelli-Chacel,Manuela Emiliana
Covas,Dimas Tadeu
Machado,Alcyone Artioli
dc.subject.por.fl_str_mv AIDS
Injected drug use
Anemia
HCV
Mycobacteria
topic AIDS
Injected drug use
Anemia
HCV
Mycobacteria
description HIV patients infected through injected drug use have poorer prognosis than other groups. We evaluated the hematological alterations and rates of co-infections in injected drug use patients with AIDS. Injected drug use patients were younger, predominantly of male gender, and presented lower CD4, total lymphocyte, and platelet counts, but not neutrophil count, than control group. Injected drug use patients had a higher rate of hepatitis C and mycobacteria infection. Furthermore, all injected drug use patients with hemoglobin <10.0 g dL-1 and lymphocyte <1000 µL-1 had CD4 count lower than 100 µL-1. In conclusion, HIV-infected injected drug use patients constitute a special group of patients, and hemoglobin concentration and lymphocyte count can be used as surrogate markers for disease severity.
publishDate 2013
dc.date.none.fl_str_mv 2013-12-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702013000600005
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702013000600005
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1016/j.bjid.2013.03.010
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Brazilian Society of Infectious Diseases
publisher.none.fl_str_mv Brazilian Society of Infectious Diseases
dc.source.none.fl_str_mv Brazilian Journal of Infectious Diseases v.17 n.6 2013
reponame:Brazilian Journal of Infectious Diseases
instname:Brazilian Society of Infectious Diseases (BSID)
instacron:BSID
instname_str Brazilian Society of Infectious Diseases (BSID)
instacron_str BSID
institution BSID
reponame_str Brazilian Journal of Infectious Diseases
collection Brazilian Journal of Infectious Diseases
repository.name.fl_str_mv Brazilian Journal of Infectious Diseases - Brazilian Society of Infectious Diseases (BSID)
repository.mail.fl_str_mv bjid@bjid.org.br||lgoldani@ufrgs.br
_version_ 1754209242783416320